How-Sung Lee
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Boon-Cher Goh (10 shared papers)Lu Fan (4 shared papers)Lingzhi Wang (8 shared papers)Soo Chin Lee (5 shared papers)Sudhir H. Ranganath (2 shared papers)Chi‐Hwa Wang (2 shared papers)Robert C. Lim (3 shared papers)Ai-Bee Ong (2 shared papers)
- Journals
- Therapeutic Drug Monitoring (5 papers)Clinical Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Biomaterials (2 papers)Pharmacogenetics and Genomics (1 paper)
- Partner nations
- SingaporeUnited StatesNew Zealand
In The Last Decade
How-Sung Lee
17 papers receiving 806 citations
Peers
Comparison fields: 5 of 95
- Pharmacology 136
- Biomaterials 146
- Biochemistry 69
- Oncology 225
- Modeling and Simulation 24
Countries citing papers authored by How-Sung Lee
This map shows the geographic impact of How-Sung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by How-Sung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites How-Sung Lee more than expected).
Fields of papers citing papers by How-Sung Lee
This network shows the impact of papers produced by How-Sung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by How-Sung Lee. The network helps show where How-Sung Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside How-Sung Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 233 | |
| 2 | 2009 | 117 | |
| 3 | 2010 | 98 | |
| 4 | 2008 | 74 | |
| 5 | 2011 | 72 | |
| 6 | 1997 | 54 | |
| 7 | 2008 | 51 | |
| 8 | 2006 | 24 | |
| 9 | 2003 | 19 | |
| 10 | 2007 | 18 | |
| 11 | 2003 | 17 | |
| 12 | 2008 | 16 | |
| 13 | 2007 | 10 | |
| 14 | 2006 | 10 | |
| 15 | 1995 | 7 | |
| 16 | 1993 | 6 | |
| 17 | 2014 | 1 |
About How-Sung Lee
How-Sung Lee is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Biological Psychiatry, Biomaterials and Pharmacology, having authored 17 papers that have together received 827 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Tryptophan and brain disorders (2 papers), Nitric Oxide and Endothelin Effects (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper), Neuroscience and Neuropharmacology Research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pharmacology (136 citations), Biomaterials (146 citations), Biochemistry (69 citations), Oncology (225 citations) and Modeling and Simulation (24 citations). How-Sung Lee has collaborated with scholars based in Singapore, United States and New Zealand. Frequent co-authors include Boon-Cher Goh, Lu Fan, Lingzhi Wang, Soo Chin Lee, Sudhir H. Ranganath, Chi‐Hwa Wang, Robert C. Lim, Ai-Bee Ong, Erin G. Schuetz and Jatinder K. Lamba. Their work appears in journals such as Therapeutic Drug Monitoring, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Biomaterials and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.